Inventor · disambiguated record
Simon David Bateman
Also filed as: BATEMAN SIMON D · BATEMAN SIMON DAVID
15 granted patents·16 pending applications·107 citations·filing 2001–2015
92Inventor score
Top patents by PatentIndex Score
31 records- 0191US7659311B2Disodium salts, monohydrates, and ethanol solvates for delivering active agentsNOVARTIS AG·Filed 2008·Granted Feb 9, 2010·8 cites·16 claims
- 0290US7049283B2Pharmaceutical compositions for the oral delivery of pharmacologically active agentsNOVARTIS AG·Filed 2001·Granted May 23, 2006·51 cites·3 claims
- 0387US7384982B2Disodium salts, monohydrates, and ethanol solvates for delivering active agentsEMISPHERE TECH INC·Filed 2003·Granted Jun 10, 2008·14 cites·3 claims
- 0483US7569539B2Oral administration of calcitoninNOVARTIS AG·Filed 2007·Granted Aug 4, 2009·7 cites·7 claims
- 0580US8207227B2Disodium salts, monohydrates, and ethanol solvates for delivering active agentsBAY WILLIAM E·Filed 2011·Granted Jun 26, 2012·2 cites·17 claims
- 0680US8003697B2Disodium salts, monohydrates, and ethanol solvates for delivering active agentsEMISPHERE TECH INC·Filed 2009·Granted Aug 23, 2011·3 cites·8 claims
- 0778US8153587B2Orally administering parathyroid hormone and calcitoninAULT JOSEPH M·Filed 2008·Granted Apr 10, 2012·6 cites·13 claims
- 0876US8765675B2Use of calcitonin in osteoarthritisAZRIA MOISE·Filed 2010·Granted Jul 1, 2014·3 cites·8 claims
- 0976US7749954B2Use of calcitonin in osteoarthritisNOVARTIS AG·Filed 2004·Granted Jul 6, 2010·7 cites·11 claims
- 1073US8435946B2Orally dosed pharmaceutical compositions comprising a delivery agent in micronized formLI SHOUFENG·Filed 2008·Granted May 7, 2013·2 cites·12 claims
- 1172US8748383B2Method for treating bone related diseases and calcium disordersLI SHOUFENG·Filed 2013·Granted Jun 10, 2014·2 cites·10 claims
- 1272US8658695B2Disodium salts, monohydrates, and ethanol solvates for delivering active agentsBAY WILLIAM ELLIOTT·Filed 2012·Granted Feb 25, 2014·2 cites·14 claims
- 1365US2009264367A15-cnac as oral delivery agent for parathyroid hormone fragmentsAZRIA MOISE·Filed 2009·Application pending·0 cites
- 1461US2008280817A1Modified amino acid for the inhibition of platelet aggregationNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1561US2006106110A1Modified amino acid for the inhibition of platelet aggregationBATEMAN SIMON D·Filed 2003·Application pending·0 cites
- 1657US9272040B25-CNAC as oral delivery agent for parathyroid hormone fragmentsAZRIA MOISE·Filed 2011·Granted Mar 1, 2016·0 cites·5 claims
- 1757US8664211B2Modified amino acid for the inhibition of platelet aggregationBATEMAN SIMON DAVID·Filed 2011·Granted Mar 4, 2014·0 cites·7 claims
- 1857US2014271735A1Use of calcitonin in osteoarthritisNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1957US2006217313A15-CNAC as oral delivery agent for parathyroid hormone fragmentsAZRIA MOISE·Filed 2006·Application pending·0 cites
- 2053US2008255048A1Pharmaceutical CompositionAZRIA MOISE·Filed 2006·Application pending·0 cites
- 2152US2004242478A15-cnac as oral delivery agent for parathyroid hormone fragmentsFiled 2002·Application pending·0 cites
- 2251US2007065505A1Orally dosed pharmaceutical compositions comprising a delivery agent in micronized formLI SHOUFENG·Filed 2004·Application pending·0 cites
- 2350US9622975B2Pharmaceutical compositionNOVARTIS AG·Filed 2015·Granted Apr 18, 2017·0 cites·8 claims
- 2450US2007231382A1Pharmaceutical compositionKARNACHI ANEES A·Filed 2007·Application pending·0 cites
- 2547US2011218148A1Pharmaceutical compositionAZRIA MOISE·Filed 2011·Application pending·0 cites
- 2646US2006135402A1Oral administration of calcitoninAZRIA MOISE·Filed 2003·Application pending·0 cites
- 2746US2007134319A1Pharmaceutical formulations of bisphosphonatesNOVARTIS AG·Filed 2004·Application pending·0 cites
- 2845US2004186050A1Method for orally administering parathyroid hormone (pth)Filed 2002·Application pending·0 cites
- 2943US2003114527A1Pharmaceutical compositionFiled 2002·Application pending·0 cites
- 3039US2004186179A1Pharmaceutical compositionFiled 2004·Application pending·0 cites
- 3133US2002061932A1Pharmaceutical compositionFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →